BLT 0.00% 2.6¢ benitec biopharma limited

So, Novartis think that Alnylam's patents are worth $10 million,...

  1. 2,381 Posts.
    lightbulb Created with Sketch. 10
    So, Novartis think that Alnylam's patents are worth $10 million, and the market thinks Alnylam are worth $10 billion.

    Kind of proves that the foundation patents don't matter anymore.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.